AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesDisciplines and OccupationsTechnology, Industry, AgricultureInformation ScienceHealth Care
Invasive Pulmonary AspergillosisAspergillosisPulmonary AspergillosisLung Diseases, FungalAspergillosis, Allergic BronchopulmonaryAspergillus fumigatusAspergillusMannansAntifungal AgentsAmphotericin BTriazolesEchinocandinsItraconazoleLipopeptidesImmunocompromised HostAntigens, FungalAspergillus flavusNeutropeniabeta-GlucansNeuroaspergillosisCortisoneOpportunistic InfectionsLungFatal OutcomeParanasal Sinus DiseasesPeptides, CyclicIodoquinolMycologyBronchoalveolar Lavage FluidMycetomaTracheitisAntibodies, FungalPyrimidinesAspergillus nigerAgranulocytosisEmericellaDeoxycholic AcidDNA, FungalZygomycosisMultiple Pulmonary NodulesRadiography, ThoracicHemoptysisTomography, X-Ray ComputedDisease Models, AnimalHematologic NeoplasmsFungal VaccinesSpores, FungalImmunosuppressionGalliumSensitivity and SpecificityDrug Resistance, FungalTreatment OutcomeMycosesLiposomesCandidiasisDrug Therapy, CombinationHyphaeDrug CombinationsBronchoscopyImmunocompetenceSputumRetrospective StudiesColony Count, MicrobialFungemiaBronchoalveolar LavageAerosolsAdrenal Cortex HormonesMice, Inbred ICRMicrobial Sensitivity TestsImmunosuppressive AgentsRabbitsPolymerase Chain ReactionCentral Nervous System Fungal InfectionsSerologic TestsDermatomycosesSurvival AnalysisMice, Inbred BALB CDrug CarriersFungal ProteinsEnzyme-Linked Immunosorbent AssayProspective StudiesGliotoxinChronic DiseaseFungal PolysaccharidesVirulenceHospital Design and Construction
ABPANational Aspergillosis CentreTuberculosisBronchiectasisAsthmaChronic cavitary pulmonary aspergillosisFibrosisForm of aspergillosisDiagnosisRespiratoryOccursInfectionsCOPDCoughAntifungalAntibodiesSerumInfiltratesFungusClinicalComplicationsAntibodyFeverFungal sporesInfection causedPneumoniaHistoplasmosisCavitiesMalignancyLungsPersistentAffectsBronchoscopyPatientCAPACommonlyLesionSeverely immunocompromisedPostoperativeDiseasesMortalitySubacuteMucoid impactionLung disease
ABPA10
  • Chest radiography results in ABPA may vary from fleeting pulmonary infiltrates to mucoid impaction to central bronchiectasis. (medscape.com)
  • Finally, an allergic response to inhaled Aspergillus results in allergic bronchopulmonary aspergillosis (ABPA) and severe asthma with fungal sensitisation. (bmj.com)
  • Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity reaction to mold that occurs when bronchi become colonized by Aspergillus fumigatus in an otherwise immunocompetent person. (bmj.com)
  • Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity reaction to Aspergillus species (generally A. fumigatus ) that occurs almost exclusively in patients with asthma or, less commonly, cystic fibrosis. (msdmanuals.com)
  • It has been observed that in Allergic Broncho-Pulmonary Aspergillosis (ABPA) both IgE and IgG are involved. (onteenstoday.com)
  • Allergic bronchopulmonary aspergillosis (ABPA) is an allergic or hypersensitive reaction to a fungus known as Aspergillus fumigatus. (aaaai.org)
  • If you have asthma, the first noticeable symptoms of ABPA are usually progressive worsening of your asthma symptoms such as wheezing and shortness of breath. (aaaai.org)
  • Allergic bronchopulmonary aspergillosis (ABPA) is at the mild end of the spectrum of disease caused by pulmonary aspergillosis and can be classified as an eosinophilic lung disease 2-4 . (radiopaedia.org)
  • Early recognition and diagnosis of allergic bronchopulmonary aspergillosis (ABPA) is critical to improve patient symptoms, and antifungal therapy may prevent or delay progression of bronchiectasis and development of chronic pulmonary aspergillosis. (bioconnections.co.uk)
  • ABPA and control sera collected at the National Aspergillosis Centre (Manchester, UK) and/or from the Manchester Allergy, Respiratory and Thoracic Surgery research biobank were evaluated using the Aspergillus ICT assay . (bioconnections.co.uk)
National Aspergillosis Centre2
  • The study was supported by the Gulu-Manchester link at Wythenshawe Hospital (part of Manchester University NHS Foundation Trust) and several donors including the NHS National Aspergillosis Centre and Astellas Pharma as well as by donations of antibody kits from Siemens. (fungaleducation.org)
  • A total of 154 CPA patient sera collected at the National Aspergillosis Centre (Manchester, United Kingdom) and control patient sera from the Peninsula Research Bank (Exeter, United Kingdom) were evaluated. (bioconnections.co.uk)
Tuberculosis11
  • Many people affected by chronic pulmonary aspergillosis have an underlying lung disease, most commonly tuberculosis, allergic bronchopulmonary aspergillosis, asthma, or lung cancer. (wikipedia.org)
  • This leads to a state known colloquially as "destroyed lung", and has features resembling treated pulmonary tuberculosis. (wikipedia.org)
  • Beyond the direct symptoms, it is possible to have general signs of underlying lung pathology such as digital clubbing-especially when there has been an underlying disease such as tuberculosis or where disease has caused heart failure (known as cor pulmonale). (wikipedia.org)
  • We revealed a high (27%) prevalence of cryptic species among previous tuberculosis patients with persistent symptoms. (manchester.ac.uk)
  • Background: Both pulmonary tuberculosis (PTB) and chronic pulmonary aspergillosis (CPA) significantly affect health-related quality of life (HR-QoL). (umn.edu)
  • These investigations include a chest radiograph and a tuberculin skin test for evidence of tuberculosis, as well as other tests indicated by the clinical symptoms. (biomedcentral.com)
  • SUMMARY: A collaboration between scientists in Manchester and Uganda reveals that around 1 in 15 tuberculosis patients go on to develop chronic pulmonary aspergillosis (CPA), via cavities left by the tuberculosis. (fungaleducation.org)
  • Around 1 in 15 people affected by tuberculosis are likely get the treatable fungal infection aspergillosis, according to research published today in the prestigious European Respiratory Journal by experts at the University of Manchester (UK) and Gulu Regional Referral Hospital (Uganda). (fungaleducation.org)
  • Page et al (2019) Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation. (fungaleducation.org)
  • Chronic pulmonary aspergillosis (CPA) often occurs in patients that have been previously treated for pulmonary tuberculosis (PTB). (manchester.ac.uk)
  • Tuberculosis and pulmonary candidiasis co-infection present in a previously healthy patient. (vestnikdv.ru)
Bronchiectasis4
  • Aspergillus bronchitis may be responsible for persistent respiratory symptoms in patients with Aspergillus detected repeatedly in sputum without evidence of parenchymal Aspergillus disease, especially in patients with bronchiectasis and cystic fibrosis. (bmj.com)
  • Early detection and treatment can prevent the development of bronchiectasis or pulmonary fibrosis that otherwise occurs in the later stages of the disease. (bmj.com)
  • Immune responses to Aspergillus antigens cause airway obstruction and, if untreated, bronchiectasis and pulmonary fibrosis. (msdmanuals.com)
  • Bronchiectasis was the most common cause of false diagnosis, followed by hydatid disease, malignancy, and aspergillosis. (tgcd.org.tr)
Asthma14
  • Whilst usually benign in nature, they can sometimes cause symptoms such as cough or an exacerbation of existing disease such as asthma. (wikipedia.org)
  • Allergic bronchopulmonary aspergillosis affects patients with asthma and cystic fibrosis, and is important to recognise as permanent lung or airways damage may accrue if untreated. (bmj.com)
  • Allergic bronchopulmonary aspergillosis is a hypersensitivity reaction to bronchial colonization by Aspergillus fumigatus mold, typically affecting patients with asthma or cystic fibrosis. (bmj.com)
  • Symptoms and signs are those of asthma with the addition of productive cough and, occasionally, fever and anorexia. (msdmanuals.com)
  • In North Carolina, a reported increase in persons presenting with asthma symptoms was postulated to be caused by exposure to mold ( 2 ). (cdc.gov)
  • In genetically susceptible individuals, these interactions can lead the patient with asthma to symptoms of breathlessness, wheezing, cough, and chest tightness. (medscape.com)
  • Clinically, patients have atopic symptoms (especially asthma ) and present with recurrent chest infections. (radiopaedia.org)
  • The symptoms of green fungus are very similar to asthma. (infoshopnetwork.org)
  • [ 59 ] A controlled prospective study has shown that adjusting inhaled corticosteroid (ICS) treatment to control sputum eosinophilia-as opposed to controlling symptoms, short-acting beta-agonist (SABA) use, nocturnal awakenings, and pulmonary function-significantly reduced both the rate of asthma exacerbations and the cumulative dose of inhaled corticosteroids. (medscape.com)
  • Total serum immunoglobulin E levels greater than 100 IU are frequently observed in patients experiencing allergic reactions, but this finding is not specific for asthma and may be observed in patients with other conditions (eg, allergic bronchopulmonary aspergillosis, Churg-Strauss syndrome). (medscape.com)
  • The chest radiograph remains the initial imaging evaluation in most individuals with symptoms of asthma. (medscape.com)
  • These include aspergillosis, an infection of the airways caused by the Aspergillus fungus, as well as the exacerbation of pre-existing conditions like rhinitis, asthma, bronchitis, hypersensitivity pneumonitis, and chronic obstructive pulmonary disease (COPD). (puremaintenanceuk.com)
  • It is recommended in:Symptoms such as allergic reactions like wheezing and coughing, especially in people suffering from asthma or cystic fibrosis. (orangehealth.in)
  • Pulmonary interstitial emphysema in fatal asthma: case report and histopathological review. (medscape.com)
Chronic cavitary pulmonary aspergillosis5
Fibrosis7
  • Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease without proven effective therapy. (ersjournals.com)
  • Idiopathic pulmonary fibrosis (IPF) is a devastating, progressive fibrotic lung disease with a median survival of 3-5 yrs without proven effective therapy 1 , 2 . (ersjournals.com)
  • MARNAC, Dallas, TX, USA) 7 - 9 is a promising agent with therapeutic potential for IPF that has combined anti-inflammatory, antioxidant and antifibrotic effects in experimental models of pulmonary fibrosis 10 - 14 . (ersjournals.com)
  • [ 3 ] Imaging findings of methotrexate-induced lung injury vary and include organizing pneumonia, acute interstitial pneumonia with noncardiogenic pulmonary edema, and fibrosis. (medscape.com)
  • Idiopathic pulmonary fibrosis (IPF) is a fatal disorder without an effective therapy to date. (atsjournals.org)
  • Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive and fatal disorder characterized by high-resolution computed tomography (HRCT) and histologic features of usual interstitial pneumonia (UIP) in adults over 50 years of age with exertional dyspnea, abnormal pulmonary function tests (PFTs), and ineffective therapy ( 1 , 2 ). (atsjournals.org)
  • Mold can also cause pulmonary fibrosis (scarring of the lungs), aspergillosis (severe lung infection), and pneumonia. (moldcleanuputah.com)
Form of aspergillosis2
Diagnosis6
  • Pulmonary nodules are a common imaging finding associated with a broad differential diagnosis. (medscape.com)
  • We present a case of Aspergillosis coexisting with PPL with multiple metastases in 54-year-old women and discuss the current knowledge on the etiology, diagnosis, and treatment of this condition. (panafrican-med-journal.com)
  • Pulmonary sequestration: is it fraught to operate without the diagnosis? (tgcd.org.tr)
  • This assay is not intended for use in invasive aspergillosis diagnosis, but for chronic forms. (bioconnections.co.uk)
  • The Aspergillus Antibody IgM test: Increased and elevated levels of IgG antibodies to are consistent with the diagnosis of aspergillosis. (orangehealth.in)
  • It aims to help people with COPD to receive a diagnosis earlier so that they can benefit from treatments to reduce symptoms, improve q. (bvsalud.org)
Respiratory11
  • The major risk factors for chronic pulmonary aspergillosis are previous cavity formation from other respiratory conditions. (wikipedia.org)
  • Aspergillosis Aspergillosis is an opportunistic infection that usually affects the lower respiratory tract and is caused by inhaling spores of the filamentous fungus Aspergillus , commonly present in. (msdmanuals.com)
  • However, aspergillosis has been increasingly reported in patients without weakened immune systems but who have severe respiratory infections caused by viruses, including influenza. (cdc.gov)
  • Clinicians should consider the possibility of aspergillosis in patients with severe COVID-19 who have worsening respiratory function or sepsis, even if they do not have classical risk factors for aspergillosis. (cdc.gov)
  • Histoplasmosis can appear as a mild flu-like respiratory illness with a combination of symptoms including malaise (a general ill feeling), fever, chest pain, dry or nonproductive cough, headache, loss of appetite, shortness of breath, joit and muscle pain, chills, and hoarseness. (cdc.gov)
  • According to the CDC , this may include allergic reactions or symptoms similar to a respiratory infection. (moldcleanuputah.com)
  • In the section on aspergillosis, the revised recommendations include the use of a room with high-efficiency particulate air filters rather than laminar airflow as the protective environment for allogeneic HSCT recipients and the use of high-efficiency respiratory-protection devices (e.g. (cdc.gov)
  • While symptoms such as coughing, wheezing, and shortness of breath may appear innocuous initially, prolonged exposure to damp and mouldy environments can lead to severe respiratory conditions. (puremaintenanceuk.com)
  • Test-retest repeatability of child's respiratory symptoms and perceived indoor air quality - comparing self- and parent-administered questionnaires. (medscape.com)
  • Evidence from China, where COVID-19 originated, shows that people who have cardiovascular and respiratory conditions caused by tobacco use, or otherwise, are at higher risk of developing severe COVID-19 symptoms [11]. (who.int)
  • Information fromChina, where COVID-19 originated, shows that people who have cardiovascular and respiratory conditions caused by tobacco use, or otherwise,are at higher risk of developingsevere COVID-19 symptoms[3]. (who.int)
Occurs4
Infections10
  • 32 The most commonly reported fungal infections in patients with COVID-19 include aspergillosis, invasive candidiasis, and mucormycosis (sometimes called by the misnomer "black fungus external icon . (cdc.gov)
  • Scientists are still learning about aspergillosis (infections caused by the fungus Aspergillus ) in people with severe COVID-19. (cdc.gov)
  • An extensive experience accrued to date in transplanting CF patients has generally allayed these concerns, demonstrating arate of bacterial pulmonary infections similar to that encountered in other patient populations 5 . (ersjournals.com)
  • Among fungal infections, aspergillosis is usually due to Aspergillus fumigatus and produces a broad spectrum of presentations, ranging from benign allergic disease to invasive infection. (biomedcentral.com)
  • It can affect many other organs causing Brain abscesses, Ear infections, Gastrointestinal Aspergillosis, etc. (infoshopnetwork.org)
  • People with a mold allergy tend to get typical hay fever or allergy symptoms such as runny nose, stuffy nose, itchy eyes, or sinus infections when the mold count in their environment is high. (amymyersmd.com)
  • Antifungals are used to treat pulmonary fungal infections (athlete's foot), as well as potentially dangerous fungal infection (aspergillosis). (antiinfectivemeds.com)
  • Secondary infections caused by opportunistic fungi (candidiasis and aspergillosis) have great social importance. (antiinfectivemeds.com)
  • Finding(s): A total of 15 patients were found to have CNS aspergillosis, 5 isolated CNS infections & 10 showing concomitant CNS & pulmonary aspergillosis in one between January 2021 to July 2022. (bvsalud.org)
  • However, when medical infrastructure is destroyed in such events and antibiotics are not available to treat infections in the early stages, pulmonary infections can fester, enter the bloodstream and spread to the brain, producing abscesses. (who.int)
COPD5
  • Chronic pulmonary aspergillosis affects patients without obvious immune compromise, but with an underlying lung condition such as COPD or sarcoidosis, prior or concurrent TB or non-tuberculous mycobacterial disease. (bmj.com)
  • Invasive pulmonary aspergillosis (IPA) is increasingly reported in chronic obstructive pulmonary disease (COPD) patients. (biomedcentral.com)
  • Nowadays, chronic obstructive pulmonary disease (COPD) has been widely recognized as a major risk factor for invasive pulmonary aspergillosis (IPA) [ 1 ]. (biomedcentral.com)
  • This guideline covers diagnosing and managing chronic obstructive pulmonary disease or COPD (which includes emphysema and chronic bronchitis) in people aged 16 and older. (bvsalud.org)
  • This guideline sets out an antimicrobial prescribing strategy for acute exacerbations of chronic obstructive pulmonary disease (COPD). (bvsalud.org)
Cough7
  • People with chronic pulmonary aspergillosis typically present with a prolonged, several month history of unintentional weight loss, chronic cough which is normally productive of sputum, shortness of breath and haemoptysis. (wikipedia.org)
  • Less common symptoms include severe fatigue or malaise, chest pain, sputum production without cough, and fever. (wikipedia.org)
  • The commonest presenting symptoms were cough (40%, n = 12) and haemoptysis (43%, n = 13). (bvsalud.org)
  • The clinical presentation ranges from an utterly asymptomatic presentation with accidental discovery on radiologic images to a wide range of nonspecific symptoms such as cough, dyspnea, and chest discomfort [ 2 ]. (panafrican-med-journal.com)
  • The most common presenting symptoms were cough and expectoration. (tgcd.org.tr)
  • Signs of aspergillosis infection may include a mild cough or even no symptoms at all. (pureaircontrols.com)
  • The common symptoms included Fever (71.4%), cough (71.3%), expectoration (44.7%) & dyspnoea (59.1%) in IPA, while in CNS aspergillosis, presented with fever (73.3%), altered sensorium (53%).The predominant risk factor included previous TB, DM, COVID-19. (bvsalud.org)
Antifungal1
  • Results of surgery for chronic pulmonary Aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence--a National Centre's experience. (bvsalud.org)
Antibodies1
Serum2
Infiltrates1
  • These opacities usually appear and disappear in different areas of the lung over a period of time as transient pulmonary infiltrates. (radiopaedia.org)
Fungus3
Clinical4
  • Both influenza-associated pulmonary aspergillosis and COVID-19-associated pulmonary aspergillosis result in high mortality and poor clinical outcomes. (ac.ir)
  • In RA patients unresponsive to treatment with traditional disease modifying antirheumatic drugs (DMARDs), therapy with a TNF antagonist has been shown to improve clinical signs and symptoms 4- , 6 and effectively inhibit radiographic progression. (bmj.com)
  • Method(s): All patients with clinical & radiological features suggestive of CNS aspergillosis were screened for microbiological evidence of invasive aspergillosis, either by demonstration of hyphae by microscopy or histology, culture or galactomannan assay. (bvsalud.org)
  • The cutoff point of clinical chronic obstructive pulmonary disease questionnaire for more symptomatic patients. (medscape.com)
Complications2
  • Which factors may be predictive of postoperative pulmonary complications among patients with pulmonary diseases? (medscape.com)
  • There is also evidence that COVID-19 patients that have more severe symptoms often have heart-related complications [21]. (who.int)
Antibody2
  • People with a positive Aspergillus antibody and any of these symptoms have a 93% chance of having CPA with 98% accuracy. (fungaleducation.org)
  • Patients with confirmed PTB from a previous study who were placed on anti-TB medication were followed up and screened for CPA at T 1 and T 2 by assessing their symptoms, evaluating their quality of life, and screening them for Aspergillus infection by performing antibody testing and cultures. (manchester.ac.uk)
Fever1
  • Mold allergies can produce similar symptoms to other allergies, such as hay fever, or seasonal allergy. (cr-slc.com)
Fungal spores1
  • Invasive aspergillosis has also been diagnosed in normal hosts after massive exposure to fungal spores. (bmj.com)
Infection caused3
Pneumonia5
  • Therefore, this study aimed to determine the frequency, risk factors, and outcomes of invasive pulmonary aspergillosis in critically ill patients with influenza, COVID-19, and community-acquired pneumonia. (ac.ir)
  • In addition, 20 (14.2%) patients were found to have invasive aspergillosis, of whom 10/35 (28.5%), 9/70 (12.8%), and 1/35 (2.8%) patients were in the COVID-19, influenza, and community-acquired pneumonia groups, respectively. (ac.ir)
  • Invasive aspergillosis and Pneumocystis jirovecii pneumonia (PJP) are less likely given the lack of constitutional symptoms, negative results for 1,3-beta-d-glucan and galactomannan on bronchoalveolar lavage, and radiographic findings that are more indicative of Mycobacterium avium complex (MAC) . (medscape.com)
  • This finding should prompt an evaluation for allergic bronchopulmonary aspergillosis, Churg-Strauss syndrome, or eosinophilic pneumonia. (medscape.com)
  • 3 Necrotizing pneumonia and pulmonary abscesses seen by the survivors of tsunamis were named tsunami lung. (who.int)
Histoplasmosis1
  • The vast majority of infected people are asymptomatic (no apparent ill effects), or they experience symptoms so mild they do not seek medical attention and may not even realize that their illness was histoplasmosis. (cdc.gov)
Cavities1
Malignancy1
Lungs3
  • The term describes several disease presentations with considerable overlap, ranging from an aspergilloma-a clump of Aspergillus mold in the lungs-through to a subacute, invasive form known as chronic necrotizing pulmonary aspergillosis which affects people whose immune system is weakened. (wikipedia.org)
  • This disease primarily affects a person's lungs, and its symptoms vary greatly. (cdc.gov)
  • TB leaves a cavity in the lungs in about 1 in 4 patients, and so with 7.7 million survivors from TB in the lungs, about 140,000 people worldwide will develop chronic pulmonary aspergillosis (CPA) every year after finishing TB therapy, assuming the results from Uganda are similar elsewhere. (fungaleducation.org)
Persistent1
  • Methods: We conducted a prospective study as part of a larger study among participants with PTB with persistent pulmonary symptoms after 2 months of anti-TB treatment at Mulago Hospital, Kampala, Uganda between July 2020 and June 2021. (umn.edu)
Affects1
  • On one end of the spectrum, invasive aspergillosis (IA) predominantly affects patients with profound defects in immune function, such as haematopoietic stem cell transplant (HSCT) or solid organ transplant recipients, and patients undergoing chemotherapy or taking corticosteroids. (bmj.com)
Bronchoscopy1
Patient1
  • The Aspergillosis Website can be a very useful resource, but of course it cannot replace the vitally important relationship each patient has with their doctor. (aspergillosis.org)
CAPA1
Commonly1
  • If there is a single, stable cavity that provides minimal symptoms, the term 'simple aspergilloma' is commonly used to distinguish it from more severe forms of chronic pulmonary aspergillosis. (wikipedia.org)
Lesion3
  • This x-ray shows a single lesion (pulmonary nodule) in the upper right lung (seen as a light area on the left side of the picture). (mountsinai.org)
  • This CT scan shows a single lesion (pulmonary nodule) in the right lung. (mountsinai.org)
  • The CNS aspergillosis was associated with ring enhancing lesion (41.6%, n=5) with leptomeningeal enhancement (50%, n=6), while cerebral abscess was seen in 16.6% (n=2) patients. (bvsalud.org)
Severely immunocompromised1
  • Invasive aspergillosis develops in severely immunocompromised patients, including those with neutropenia, and increasingly in the non-neutropenic host, including lung transplant recipients, the critically ill patients and patients on steroids. (bmj.com)
Postoperative1
  • Aspergillus fumigatus is the most common species implicated in all pulmonary syndromes, although Aspergillus flavus is a more common cause of various forms of allergic rhinosinusitis, postoperative aspergillosis and fungal keratitis. (bmj.com)
Diseases6
  • It is more common in people who are elderly or dependent on alcohol, or with diseases such as diabetes, malnutrition, chronic obstructive pulmonary disease or HIV/AIDS. (wikipedia.org)
  • Overview of Eosinophilic Pulmonary Diseases Eosinophilic pulmonary diseases are a heterogeneous group of disorders characterized by the accumulation of eosinophils in alveolar spaces, the interstitium, or both. (msdmanuals.com)
  • Aspergillosis is primarily seen in immunocompromised patients or those with underlying chronic lung diseases. (panafrican-med-journal.com)
  • Invasive pulmonary aspergillosis is known to complicate the coronavirus diseases-2019 (COVID-19), especially those with critical illness. (bvsalud.org)
  • In addition, there is an increased risk of more serious symptoms and death among COVID-19 patients who have underlying conditions, including cardiovascular diseases (CVDs) [17] [18]. (who.int)
  • There isan increased risk of more serious symptoms and death among COVID-19 patients that have underlying cardiovascular diseases (CVDs)[11][12]. (who.int)
Mortality1
Subacute1
Mucoid impaction1
  • Pulmonary collapse may be seen as a consequence of endobronchial mucoid impaction. (radiopaedia.org)
Lung disease1
  • Chronic pulmonary aspergillosis (CPA) presents in a more indolent fashion, usually affecting patients with underlying lung disease, but with no or only subtle generalised immune compromise. (bmj.com)